MJP Associates Inc. ADV Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

MJP Associates Inc. ADV cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,579 shares of the healthcare conglomerate’s stock after selling 61 shares during the quarter. UnitedHealth Group accounts for about 0.4% of MJP Associates Inc. ADV’s portfolio, making the stock its 28th largest holding. MJP Associates Inc. ADV’s holdings in UnitedHealth Group were worth $1,324,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. Signature Estate & Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 1.2% during the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock worth $820,000 after purchasing an additional 19 shares during the last quarter. Steph & Co. raised its position in UnitedHealth Group by 1.6% in the first quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock worth $658,000 after acquiring an additional 20 shares in the last quarter. First City Capital Management Inc. raised its position in UnitedHealth Group by 1.5% in the first quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock worth $688,000 after acquiring an additional 20 shares in the last quarter. Griffin Asset Management Inc. raised its position in UnitedHealth Group by 0.3% in the first quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after acquiring an additional 21 shares in the last quarter. Finally, Physicians Financial Services Inc. raised its position in UnitedHealth Group by 5.2% in the first quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock worth $216,000 after acquiring an additional 21 shares in the last quarter. 87.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on UNH. Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Morgan Stanley raised their price target on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research report on Thursday, September 8th. Argus increased their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research note on Monday, July 25th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $521.02 on Monday. The stock’s 50-day moving average is $529.29 and its 200-day moving average is $511.81. The company has a market cap of $487.35 billion, a price-to-earnings ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same period last year, the business posted $4.70 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Monday, September 12th will be issued a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. UnitedHealth Group’s payout ratio is currently 34.46%.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the sale, the executive vice president now directly owns 8,104 shares in the company, valued at approximately $4,043,896. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the sale, the executive vice president now directly owns 8,104 shares in the company, valued at approximately $4,043,896. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares in the company, valued at $40,415,496.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 140,324 shares of company stock worth $75,086,185. 0.40% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.